Market Place
Sourcing Support
ANI Pharma to Present at 36th Annual Piper Sandler Conference
26 Nov 2024 //
GLOBENEWSWIRE
ANI Pharma Reports Q3 2024 Financial Results & Raises 2024 Guidance
08 Nov 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals to Present at Guggenheim & Jefferies
04 Nov 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals to Discuss Q3 Results on Nov 8, 2024
30 Oct 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Launches FDA-Approved Estradiol Gel
25 Oct 2024 //
GLOBENEWSWIRE
ANI Pharma Presents Membranous Nephropathy Data At ASN 2024
24 Oct 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Announces FDA Approval Of Ketoconazole Shampoo
26 Sep 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Initiates Alimera Sciences Acquisition
16 Sep 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Launches New Oral Solution Product
13 Sep 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
11 Sep 2024 //
GLOBENEWSWIRE
Ani Pharmaceuticals Updates On Alimera Sciences Acquisition
10 Sep 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Closes $316.25M Convertible Senior Notes Offering
13 Aug 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
07 Aug 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Prices Upsized $275.0M Convertible Senior Notes Offering
07 Aug 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Reports Q2 2024 Results, Raises 2024 Guidance
06 Aug 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals To Discuss Q2 2024 Results On August 6
31 Jul 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals` L-Glutamine Oral Powder Approved And Launched By FDA
15 Jul 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets
02 Jul 2024 //
GLOBENEWSWIRE
ANI `s Nikhil Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
25 Jun 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals To Acquire Alimera Sciences
24 Jun 2024 //
CONTRACT PHARMA
ANI Pharma to Discuss Fourth Quarter and Full Year 2023 Financial Results
07 Feb 2024 //
GLOBENEWSWIRE
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Tablets, USP
23 Jan 2024 //
GLOBENEWSWIRE
ANI Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
22 Nov 2023 //
GLOBENEWSWIRE
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
30 Oct 2023 //
GLOBENEWSWIRE
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
18 Sep 2023 //
GLOBENEWSWIRE
ANI Pharma Appoints Executive Matthew J. Leonard to its Board of Directors
23 Aug 2023 //
GLOBENEWSWIRE
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
22 May 2023 //
BUSINESSWIRE
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock
16 May 2023 //
BUSINESSWIRE
ANI Pharma Announces FDA Approval & Commercialization of Two &As with CGT
15 May 2023 //
BUSINESSWIRE
ANI Pharma Announces Pricing of $75 Million Public Offering of Common Stock
12 May 2023 //
BUSINESSWIRE
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 May 2023 //
BUSINESSWIRE
ANI Pharmaceuticals to Discuss 1Q 2023 Financial Results on May 8, 2023
27 Apr 2023 //
BUSINESSWIRE
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin
24 Apr 2023 //
BUSINESSWIRE
ANI Pharma Announces the FDA Approval of Colestipol Hydrochloride Tablets USP
04 Apr 2023 //
BUSINESSWIRE
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results
09 Mar 2023 //
BUSINESSWIRE
ANI Pharma to Discuss Fourth Quarter and Full Year 2022 Financial Results
22 Feb 2023 //
BUSINESSWIRE
ANI Pharm`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
ANI Pharma Announces the FDA Approval and Launch of Levocarnitine Tablets USP
19 Dec 2022 //
BUSINESSWIRE
ANI Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
28 Nov 2022 //
BUSINESSWIRE
ANI Pharma Announces the FDA Approval and Launch of Trimethoprim Tablets USP
16 Nov 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results
09 Nov 2022 //
BUSINESSWIRE
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results
24 Oct 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer
12 Sep 2022 //
BUSINESSWIRE
ANI to Present at the H.C. Wainwright 24th Annual Global Investment Conference
30 Aug 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
29 Aug 2022 //
BUSINESSWIRE
ANI Pharma Announces FDA Approval and Launch of Dexamethasone Tablets USP
16 Aug 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
BUSINESS WIRE
ANI Pharma Announces the Launch of Acebutolol Hydrochloride Capsules USP
03 Aug 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC
28 Jul 2022 //
BUSINESSWIRE
ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results
25 Jul 2022 //
BUSINESSWIRE
ANI Pharma Appoints M. W. Cook as SVP, General Counsel and Corporate Secretary
18 Jul 2022 //
BUSINESSWIRE
ANI focuses on data insights to ramp up Cortrophin
24 Jun 2022 //
FIERCEPHARMA
ANI Pharmaceuticals Announces Consolidation of Manufacturing Network
02 Jun 2022 //
BUSINESSWIRE
ANI Pharma Announces FDA Approval and Launch of Fludrocortisone Acetate Tablets
01 Jun 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Reports First Quarter 2022 Results
10 May 2022 //
BUSINESSWIRE
ANI Pharma to Discuss First Quarter 2022 Financial Results on May 10, 2022
19 Apr 2022 //
BUSINESSWIRE
ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets
11 Apr 2022 //
BUSINESSWIRE
ANI Pharma Reports Q4 and FY 2021 Results; Strong Foundation in Place
15 Mar 2022 //
BUSINESSWIRE
ANI Pharmaceuticals to Discuss Q4 and Full Year 2021 Financial Results
07 Mar 2022 //
BUSINESSWIRE
